Image

Global Daptomycin Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Dec 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Dec 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Daptomycin Market, By Indication (Complicated Skin Structure Infections, Bacteremia, Others), Age Group (Paediatric, Adult), Strength (350mg, 500mg), End-User (Pharmaceuticals, Clinics, Wellness Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Daptomycin Market Market Analysis and Insights : Global Daptomycin Market

Daptomycin market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 5,509.53 million by 2028 growing at a CAGR of 4.27% in the above-mentioned forecast period. The growing awareness amongst the patients regarding the benefits of the daptomycin which will further create new opportunities for the growth of the market.

Daptomycin is a naturally occurring lipopeptide antibiotic that, by disrupting its membrane potential, destroys susceptible gram-positive bacteria. It is contained in streptomyces rose sports, a soil bacterium. In the treatment of infections caused by bacteria, antibiotics are used. They work by killing bacteria or by preventing their growth.

Surging volume of patients suffering from skin and skin structure infections, rising role as an antibacterial drug, a bacterial metabolite, and a member of calcium-dependent antibiotics, growing infections in the bloodstream including sepsis, availability of the medicinal products, prevalence of improved healthcare infrastructure are some of the vital as well as important factors which will likely to accelerate the growth of the daptomycin market in the projected timeframe of 2021-2028. On the other hand, growing number of research and development activities along with prevalence of favourable reimbursement policies which will further contribute by generating immense opportunities that will led to the growth of the daptomycin market in the above mentioned projected timeframe.

Increasing rates of infection with gram-positive bacteria along with rising usages of new drug to avoid the rapid emergence of resistance to the new agent which will likely to act as market restraints factor for the growth of the daptomycin in the above mentioned projected timeframe.

This daptomycin market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on daptomycin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Daptomycin Market Scope and Market Size

Daptomycin market is segmented on the basis of indication, age group, end-user, and strength. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on indication, the daptomycin market is segmented into complicated skin structure infections, bacteremia, and others. Others have been further segmented into methicillin-resistant staphylococcus aureus (MRSA) or superbug infections. Complicated skin structure infections segment will expect to hold the largest market share in the forecast period.
  • Daptomycin market has also been segmented based on the age group into paediatric, and adult. The adult segment will expect to hold the largest market share due to the increasing number of bacteremia and right-sided infective endocarditis patients.
  • Based on strength, the daptomycin market is segmented into 350mg, and 500mg.
  • On the basis of end-user, the daptomycin market is segmented into pharmaceuticals, clinics, and wellness centers.  

Daptomycin Market Country Level Analysis

Daptomycin market is analysed and market size insights and trends are provided by country, indication, age group, end-user, and strength as referenced above.

The countries covered in the daptomycin market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

The U.S. dominates the North America daptomycin market due to the increasing occurrences of complicated skin and skin structure infections along with increasing number of research activities for the development of drugs in the region. Europe will hold the second largest position in the daptomycin market due to the rising cases of MSRA along with approval of an expanded marketing authorization for cubicin in the region, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2021 to 2028 due to the increasing occurrences of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) and community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in the region.

The country section of the daptomycin market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Daptomycin market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for daptomycin market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the daptomycin market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Daptomycin Market Share Analysis

Daptomycin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to daptomycin market.

The major players covered in the daptomycin market report are Teva Pharmaceutical Industries Ltd; Merck & Co., Inc.; Cipla Inc.; Pfizer Inc.; Biological E Limited.; Dr. Reddy’s Laboratories Ltd.; Mylan N.V.; Fresenius Kabi USA; Nichi-Iko Pharmaceutical Co., Ltd.; Sagent Pharmaceuticals, Inc.; Novo Holdings A/S; HISUN USA, inc.; Jiangsu Hengrui Medicine; Huadong Medicine Co.,Ltd; CIVICA.; Olon S.p.A.; Zhejiang Medicines and Health; Yacht Bio-Tech Co., Ltd.; Chongqing Daxin Pharmaceutical Co., Ltd.; Socosur Chem; among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-
Why Choose Us


Frequently Asked Questions